This interlaboratorystudy was
the HF analytical signal is derived from zinc protoperphyrin (ZPP), rather than protoporphyrun IX (PPIX). ZPP fluoresces at 596 nm (Soret band); the emitted light is focused onto a red-sensitive photomultiplier tube. Hemoglobin (Hb) strongly absorbs in the Soret region, so the emission intensity is a function of the molar ratio of ZPP to Hb, and is given by: 
MaterIals and Methods

Participants
The original idea of this interlaboratory study came from a joint meeting of laboratory experts in the field of lead poisoning representing the HF manufacturers, and health officials at the state and federal level.7 Three reference laboratories1'34 were selected to evaluate the materials. These laboratories were chosen because of their combined roles in conducting proficiency testing programs at both the state1 and federal8 level, and in coordinating the CDC's National Health and Nutrition Examination Surveys, which include erythrocyte protoporphyrin. 4 Thus, the combined reference laboratories possess considerable expertise in the protoporphyrin field, and each operates a routine analytical program for determination of EP by extraction. Therefore, each of these laboratories has the advantage of 7This meeting took place at the invitation of the U.S. Dept. of Health and Human Services, Health Resources and Services Administration, Rockville, MD, in September 1985.
being able to calibrate their own HFs in situ against the EEP method using human blood specimens.
Control Materials
The following control materials were selected for evaluation: (a) ZP controls from Aviv Biomedical Inc., Lakewood A total of five HFs were used in this study, two Aviv ZPP (Aviv Biomedical, Inc.) HFs and three ESA Model 4000 HFs (Environmental Science Associates, Bedford, MA 01730). At the request of Aviv Biomedical, Inc., the two Aviv HFs involved in the study were serviced and recalibrated in the factory before the study.
InstrumentCalibrationProcedure
The task of HF calibration is complicated by the absence of a primary ZPP/hemoglobin standard and by the fact that most HFs are calibrated to convert the analytical signal into a digital reading that displays micrograms equivalent EP per deciliter of whole blood, for an assumed hematocrit of either 35% or 42%. In view of this, a calibration procedure similar to that described independently by Peter et al. (3) was developed, whereby HEP data were obtained regularly on about 30 to 40 human blood specimens for which both EEP and hematocrit (or Hb) data had also been determined. The HEP data were corrected to a hematocrit of 35% by use of the following formula:
One of the reference laboratories8 elected to report Hb values on patients' specimens rather than hematocrits. Lu this case, Hb data were converted to an "equivalent" hematocrit by using the following relationship:
We plotted corrected HEP data vs the corresponding EEP data, using simple linear-regression analysis. Outliers were identified by inspecting the standardized residuals and were rejected if the residuals fell outside the interval -1 I 1. Simple linear regression was applied again, and the equation of the line was used to predict EEP values for each of the materials being studied with five HFs. This procedure was carried out twice monthly on each HF used in the study. All data from each reference laboratory were returned to the coordinating laboratory for statistical analysis to ensure identical treatment. The use of this calibration procedure eliminated changes associated with an individual instrument's bias and (or) drift during the course of the evaluation period. A preliminary protocol was circulated to each reference laboratory and to the manufacturers for review. This prompted several changes, including extending the study to allow evaluation of the materials stored at room temperature, frozen, and refrigerated.
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Each manufacturer agreed to provide high-, medium-, and low-concentration control materials for evaluation. Manufacturers were responsible for preparing their own materials in containers of their choice that would not reveal the identity of their product. All materials used in the study were sent to the coordinating laboratory,1 where each container was re-labeled with a code, known only to the coordinator, that identified the material, the manufacturer, and the concentration as high, medium, or low. The coded materials were forwarded to the other reference laboratories for evaluation. Thus, inasmuch as it was possible, a blind evaluation was conducted by the other two reference laboratories.8'4 The evaluation was divided into three parts corresponding to the three storage temperatures: room (about 20#{176}C), refrigerated (2 to 4 #{176}C), and frozen (-10 to -20 #{176}C).
Room-temperature materials. Each laboratory received 1-mL aliquots of each material in high, medium, and low concentrations. These were stored at room temperature for one month, during which they were analyzed in a total of five HFs in the three laboratories. At least twice a week, HEP data were obtained on fresh (never more than three days old) human blood specimens that had also been analyzed for EEP. These data were used later to establish a calibration line for each instrument, as described above, and predict equivalent EEP values for each data point during a one-month period.
Refrigerated materials. Each laboratory also received 5-mL aliquots of each material in high, medium, and low concentrations. These were stored at 4 to 8#{176}C for one year, thus simulating typical laboratory storage conditions. This section of the study formed the basis of the stability evaluation. The reference laboratories collected HEP, EEP, and hematocrit data from their own selected patient pools. Twice monthly, the materials were removed from the refrigerator, allowed to warm to room temperature, and analyzed in each HF. All data were forwarded to the coordinating laboratory for subsequent linear-regression analysis as described above.
Frozen materials. In addition, each laboratory received 12 sets of 0.5-mL vials containing high, medium, and low concentrations (one analysis per month for one year). These were stored between -10 and -20#{176}C for a year. Once a month, one 0.5-mL set of materials was removed, allowed to thaw to room temperature, analyzed in the HF, then discarded. All data were forwarded to the New York laboratory' for subsequent linear-regression analysis.
EthylAcetate-Acetic Acid Extraction Method (EEP)
Each laboratory agreed to analyze their human blood specimens for EP, using a consensus ethyl acetate-acetic acid extraction procedure8 (EEP) developed from procedures published previously by Piomeffi (9), Chisolm and Brown (10), andSassaetal. (11) .
Blood specimenswere diluted with water and extracted in ethyl acetate:acetic acid (4:1 by vol) in glass culture tubes. This separated porphyrin and heme components from cellular debris. On addition of 1.5 mol/L HC1, protoporphyrin was extracted back into the acid phase, where ZPP dissociated into "free" PP1X and 2+
ions. For primary calibration we used protoporphyrin IX, which was standardcopy of this method, which is the product of many years' collective experience in the protoporphyrin field, may be obtained upon request from the first author (P.J.P.).
ized by molecular absorption spectrophotometry, a value for millimolar absorptivity of 241 being used in the calculation.9 Samples, standards, and controls were analyzed by conventional molecular fluorometry, the excitation wavelength being 408 nm and the emission wavelength 662 urn. This analysis is often referred to as the "free" erythrocyte protoporphyrin test, because at low pH the PPIX molecule is actually "free," i.e., dissociated from the Zn2 ion. Within the erythrocyte, however, most PPIX is present in the form of a labile complex as ZPP, although the ratio of ZPP to total PPIX varies among species. For humans, this ratio is approximately 0.90(15).
StatisticalEvaluationof the Final Results
Our use of four control materials, each at three concentrations and three storage temperatures, resulted in 36 experimental conditions under which data were obtained separately by the three reference laboratories,"3'4 each using one or two different HFs (Aviv or ESA). Data were taken repeatedly during different storage intervals (maximum of 31 days for room-temperature storage, 338 days for refrigerated, and 367 days for frozen). The initial analysis investigated each of the resulting 180 sets of data for responses over time.
Of particular interest was the possibility that the first data segment had a slope of zero, indicating the control material to be stable over some initial period, while the second segment has a slope not equal to zero, indicating that the material gave altered results thereafter. This hypothesis was tested by comparing the time trends fit with two intersecting line segments to the fit of a single line. For this purpose, 180 two-phase regressions were fitted (16) and tested for the statistical significance of including a second slope. The large number of tests performed necessitated decreasing the significance level to 0.00028 to ensure that there was only a 5% probability of detecting a significant two-phase regression by chance alone among the 180 Simultaneous hypotheses (17) . As in any interlaboratory study where each laboratory draws on its own population of subjects and uses its own equipment, an objective of the analysis was to produce single interlaboratory consensus estimates. These estimates must explicitly account for interlaboratory differences that arise, for example, from (a) reporting Hb instead of hematocrit, (b) changes in the HF calibration mediated by differing ranges of patients' EP concentrations, and (c) changes in the number of patients available.
These differences result in inhomogeneities in the precision with which each laboratory determines EEP values. The consensus estimates can account for these differences by discounting data from a particular laboratory/machine of low precision and augmenting data of high precision. Proper amounts of discounting/augmentation result in consensus estimates of maximum possible precision.
9One major problem still remains. The millimolar absorptivity of protoporphyrin IX, the principal primary calibration standard, was originally determined to be 241.0 L mmol' cm' (12). However, the accuracy of this value has been questioned recently (13), where it was reported to be 297.0 L mmol' cm'-a value that appears to agree well with values determined earlier elsewhere (14). Notwithstanding this, most laboratories in the U.S. have agreed to continue using the former value (241) until a definitive value is published and the U.S. Dept. of Health and Human Services, Centers for Disease Control revises its risk classifications (1) in the light of the correct value. 
Time in Days
For this purpose, the five data sets for each of the 36 conditions (four materials x three concentrations x three temperatures)
were weighted with weights inversely proportional to the variance-covariance matrices of the slope and intercept, such that the weights were greater than zero, summed to one, and minimized the variances of the final estimates. This was accomplished by assigning the mostvariable data sets the smallest weights and the least-variable data sets the largest weights. This matrix-weighting scheme resulted in separate weights being applied for the slope and intercept but simultaneously accounted for the correlation between them. The precision of the final estimates was further enhanced by removing outliers with standardized residuals exceeding 2.3 standard deviations before the weighted regression lines were cal#{232}ulated.
Results
None of the two-phase regressions showed statistical significance for inclusion of a second regression line. Therefore, all regressions were run in single-phase.
Although a single laboratory/machine combination with very low concentrations in the data for frozen samples had 20% of data deleted by the outlier criterion, the overall temperaturespecific deletions were 4.25% for room temperature, 7.8% for refrigerated, and 5.12% for frozen. Data for one specific control material (Contox), which was stored refrigerated, are shown in two dimensions in Figure 1 to clarifS' the nine temperature-concentration-specific figures (Figure 2 ) that follow. Figures 1 and 2 show undeleted data points, but with consensus regressions (calculated after outlier rejection), 95% confidence intervals, and the acceptable ranges (± 15% of the intercept for values 40 tg/100 mL, and ±6 ig for values <40) as defined by federal and New York State criteria. Days in range were counted from the initiation of the study to the time at which either the upper or lower 95% confidence interval exceeded the fixed criteria for the acceptable range. Individual parameter estimates and various other summary measures appear in Table 1 The ProtoFluor material gave the greatest variability with temperature, even though it had the smallest change across concentration. For each material, results for the refrigerated and frozen temperatures were similar in being the most stable. Room-temperature storage gave the most instability, particularly for the Contox material. For the Aviv, Contox, and New York materials, increased concentrations led to greater instability, the first two changing positively but the latter changing negatively. The concentration differences in stability for room temperature storage of the ProtoFluor material were not consistently in the same direction. Table 1 shows the differences between the estimated intercept (i.e., at t = 0) and the manufacturers' supplied target value for each material, by concentration combination, and by temperature.
Because the New York laboratory uses the consensus of several reference laboratories, including those participating in this study, to assign target values in its proficiency program, there was little point in calculating a "manufacturers" target value. It should also be noted that the New York material is not a commercial product but a standard reference material developed for the purpose of proficiency testing of clinical laboratories using the HF.
As for the three commercial materials, intercepts determined at room-temperature storage were closest to the manufacturer's stated target value. However, the largest discrepancy was observed with the Aviv material at the high concentration, which was 28 1tg/dL too low for each temperature;
the Aviv medium level ran about 10 g/dL too low, and the low concentration 4 pg/dL too high. Other large differences included 29 pg/dL too high for ProtoFluor medium-concentration frozen, as well as 23 and 25 ug/dL too high for the high-concentration frozen and refrigerated.
DIscussion and Conclusion
The short history of hematofluorometry has been characterized by much controversy. This is due in part to the lack of consensus that surrounds the traditional extraction method and to a decision taken some 10 years ago to report EP in units of micrograms of EP per deciliter of "whole blood," rather than the more "scientifically and physiologically correct" units of micrograms of EP per 100 mL of erythrocytes (or preferably micrograms of EP per gram of Hb, which does not require a correction for the hematocrit status of the patient). Since then, the units micrograms per deciliter of whole blood have become entrenched in the lead-poisoning field. In the interests of continuity, HF manufacturers were encouraged to calibrate their instruments in these units, with an assumed hematocrit depending on the population.
In the absence of a primary standard, manufacturers calibrated their HFs either against human blood that had been analyzed for EEP, or against I blood-based control materials. As use of the HF grew, various problems that are peculiar to the instrument became apparent. Most notable was a strange phenomenon that occurs with some blood specimens and which results in readings that are much too high and do not agree with values obtained by extraction. These effects can be attributed in part to increased bilirubin, which fluoresces at the same wavelength as ZPP (18, 19) . Riboflavin has also been suggested as a factor that may cause elevation of HEP measurements (7) . In a few rare circumstances, patients This study has demonstrated that, of all the materials that are currently available, each has some good and bad points, and each could be improved upon to some extent. Aviv's ZP control proved to be the most stable material over the time-frame studied. This material is prepared from human blood by a procedure similar to that used to prepare the New York State material (20) . However, Aviv's target values did not agree at the high concentration with those determined by a consensus of reference laboratories. This raises serious questions about the basic calibration process that is performed by this manufacturer on their HFs. The fact that Aviv use their blood-based control materials to calibrate a "master instrument," and thereby the vast majority of field instruments, goes a long way to explaining the negative bias, particularly at the high end, that has been observed for their HFs on state and federal proficiency testing programs.1#{176} Indeed, Aviv reportedly sets the target '#{176}The manufacturer, Aviv Biomedical, was informed of these findings presented here. As a result, they promptly agreed to change their procedure for assigning target values, and thereby the calibration procedure for their HF. In future, Aviv's target values will be assigned by the reference laboratories that participated in this study, with use of HFs that are directly calibrated against whole human blood specimens analyzed for EEP. 
